Cytogenetic and interphase Fluorescence in Situ Hybridization studies in patients with multiple myeloma

被引：0
|
作者：
G Perumal
RS Chandra
P Prabu
N Indhumathi
Anil Tarigopula
Rama Mani
机构：
[1] Apollo Hospitals,Department of Molecular Biology and Cytogenetics
[2] University of Madras,Department of Genetics, Dr. ALM PG. Institute of Basic Medical Sciences
来源：
Molecular Cytogenetics | / 7卷 / Suppl 1期
关键词：
Multiple Myeloma; Plasma Cell; Chromosomal Abnormality; Plasmacytomas; Monoclonal Gammopathy;
D O I：
10.1186/1755-8166-7-S1-P20
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization
    Slovak, ML
    Bedell, V
    Pagel, K
    Chang, KL
    Smith, D
    Somlo, G
    [J]. CANCER GENETICS AND CYTOGENETICS, 2005, 158 (02) : 99 - 109
  • [42] Cytogenetics of multiple myeloma:: interpretation of fluorescence in situ hybridization results
    Harrison, CJ
    Mazzullo, H
    Cheung, KL
    Gerrard, G
    Jalali, GR
    Mehta, A
    Osier, DG
    Orchard, KH
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (06) : 944 - 952
  • [43] STUDIES OF METAPHASE AND INTERPHASE CHROMOSOMES USING FLUORESCENCE IN-SITU HYBRIDIZATION
    TRASK, BJ
    ALLEN, S
    MASSA, H
    FERTITTA, A
    SACHS, R
    VANDENENGH, G
    WU, M
    [J]. COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1993, 58 : 767 - 775
  • [44] Fluorescence in situ hybridization analysis of chromosome aberrations in 60 Chinese patients with multiple myeloma
    Xiao Gao
    Chunming Li
    Run Zhang
    Ruifang Yang
    Xiaoyan Qu
    Hairong Qiu
    Jiaren Xu
    Hua Lu
    Jianyong Li
    Lijuan Chen
    [J]. Medical Oncology, 2012, 29 : 2200 - 2206
  • [45] Fluorescence in situ hybridization analysis of chromosome aberrations in 60 Chinese patients with multiple myeloma
    Gao, Xiao
    Li, Chunming
    Zhang, Run
    Yang, Ruifang
    Qu, Xiaoyan
    Qiu, Hairong
    Xu, Jiaren
    Lu, Hua
    Li, Jianyong
    Chen, Lijuan
    [J]. MEDICAL ONCOLOGY, 2012, 29 (03) : 2200 - 2206
  • [46] Longitudinal genetically detectable minimal residual disease by interphase fluorescence in situ hybridization confers a poor prognosis in multiple myeloma
    Cui, Jian
    Yu, Tengteng
    Yan, Wenqiang
    Xu, Jingyu
    Liu, Jiahui
    Fan, Huishou
    Qiu, Lugui
    An, Gang
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S226 - S226
  • [47] Monitoring of minimal residual disease in multiple myeloma by trisomy 9 cell detection using interphase fluorescence in situ hybridization
    Dascalescu, CM
    Nicolini, FE
    Molina, L
    Garban, F
    Chauvet, M
    Sotto, JJ
    Leroux, D
    [J]. EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 626 - 626
  • [48] Residual risk for cytogenetic abnormalities after prenatal diagnosis by interphase fluorescence in situ hybridization (FISH)
    Homer, J
    Bhatt, S
    Huang, B
    Thangavelu, M
    [J]. PRENATAL DIAGNOSIS, 2003, 23 (07) : 566 - 571
  • [49] CYTOGENETIC STUDIES IN PATIENTS WITH MULTIPLE-MYELOMA
    KOWALCZYK, JR
    DMOSZYNSKA, A
    CHOBOTOW, M
    SOKOLOWSKA, B
    [J]. CANCER GENETICS AND CYTOGENETICS, 1991, 55 (02) : 173 - 179
  • [50] Cytogenetic and fluorescence in situ hybridization studies in a case of anaplastic thyroid carcinoma
    Roque, L
    Soares, J
    Castedo, S
    [J]. CANCER GENETICS AND CYTOGENETICS, 1998, 103 (01) : 7 - 10
12345